Fertility and sterility, 115(1), 54-61, 2021

Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I

Eisenberg ML , Dolores J Lamb , Steven D. Spandorfer

Author affiliations (4)
  • Baylor College of Medicine ROR
  • Cornell University ROR
  • St Mary's Hospital Centre ROR
  • University of Southern California ROR
DOI10.1016/j.fertnstert.2020.11.015 PMID33309062
Read at publisher

Abstract

Purpose

The summary presented herein represents Part I of the two-part series dedicated to the Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline. Part I outlines the appropriate evaluation of the male in an infertile couple. Recommendations proceed from obtaining an appropriate history and physical exam (Appendix I), as well as diagnostic testing, where indicated.

MATERIALS/

Methods

The Emergency Care Research Institute Evidence-based Practice Center team searched PubMed®, Embase®, and Medline from January, 2000 through May, 2019. When sufficient evidence existed, the body of evidence was assigned a strength rating of A (high), B (moderate), or C (low) for support of Strong, Moderate, or Conditional Recommendations. In the absence of sufficient evidence, additional information is provided as Clinical Principles and Expert Opinions. (Table 1) This summary is being simultaneously published in Fertility and Sterility and The Journal of Urology.

Results

This Guideline provides updated, evidence-based recommendations regarding evaluation of male infertility as well as the association of male infertility with other important health conditions. The detection of male infertility increases the risk of subsequent development of health problems for men. In addition, specific medical conditions are associated with some causes for male infertility. Evaluation and treatment recommendations are summarized in the associated algorithm. (Figure 1)

Conclusion

The presence of male infertility is crucial to the health of patients and its effects must be considered for the welfare of society. This document will undergo updating as the knowledge regarding current treatments and future treatment options continues to expand.

PMID 33309062 33309062 DOI 10.1016/j.fertnstert.2020.11.015 10.1016/j.fertnstert.2020.11.015